BioSpace News Archive

Concord Medical Services Holdings Limited today announced that it will hold its 2022 annual general meeting of shareholders (the “Meeting”) on December 30, 2022, at 10:00 a.m. (Beijing Time).

Can-Fite BioPharma Ltd. today announced financial results for the quarter ended September 30, 2022.

Regulatory News: Aptorum Group Limited is pleased to announce the recent publication of a joint effort for the validated analytical method developed for the determination of plasma pro-EGCG and its metabolites after oral administration using ultra performance liquid chromatography coupled to quadrupole time of flight mass spectrometry.

The Centre Hospitalier Universitaire Vaudois in Lausanne, Switzerland, the European Laboratory for Particle Physics and THERYQ have signed an agreement for the world-first development of a revolutionary FLASH radiotherapy device that will use very high energy electron radiation to treat cancers resistant to conventional treatments.

Mednow Inc. is pleased to announce the Company will be hosting its quarterly conference call on Tuesday November 29, 2022 at 8:30am EST.

Captor Therapeutics S.A. reports its financial results for the third quarter of 2022 and provides a business update.

Liminal BioSciences Inc. announced that it will be holding a virtual special meeting of shareholders on January 20th, 2023.

SwiftMR™, an AI-powered MRI reconstruction solution from AIRS Medical proved its performance for enhancing the image quality of 3D high-resolution MRI.

Nordic Nanovector ASA has today launched a new dedicated area on its website ( www.nordicnanovector.com ) with information in Norwegian for shareholders relating to its proposed merger with APIM Therapeutics (“APIM”).

Hyundai Bioscience announced on November 24th, 2022, that it is collaborating with an Australian cancer hospital for its global Phase 1 clinical trial on pancreatic cancer with Polytaxel, which was developed as so-called ‘pain-free’ anticancer drug, based on a novel inorganic polymer nanohybrid drug delivery platform technology.